Home LiteratureArticle Details
PMID: 7855619 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Chemotherapy for advanced renal-cell carcinoma: 1983-1993.

Seminars in oncology ·Vol. 22 ·No. 1 ·1995-02-00 ·Pages 42-60

Yagoda A, Abi-Rached B, Petrylak D

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/therapeutic use Antineoplastic Combined Chemotherapy Protocols/therapeutic use Carcinoma, Renal Cell/drug therapy,mortality Clinical Trials, Phase II as Topic/statistics & numerical data Drug Resistance Female Humans Incidence Kidney Neoplasms/drug therapy,epidemiology,mortality Male Survival Rate Treatment Outcome
Chemicals
Antineoplastic Agents
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Yagoda A
Medical Oncology Division, Columbia-Presbyterian Medical Center, New York, NY 10032-3789.
Abi-Rached B
Petrylak D
Article Info
Journal
Seminars in oncology
Abbr.
Semin Oncol
ISSN
0093-7754
Published
1995-02-00
Pages
42-60
Language
English
Region
United States
NLM ID
0420432
Subset
IM
Grants
NCI NIH HHS · CA 13696 · United States
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2